Farley M M.Group B streptococcal disease in nonpregnant adults[J].Clinical Infectious Diseases,2001,33(4):556-561.
[2]
Martins E R,Florindo C,Martins F,et al.Streptococcus agalactiae serotype Ib as an agent of meningitis in two adult nonpregnant women[J].Journal of Clinical Microbiology,2007,45(11):3850-3852.
[3]
Cordoba-Lopez A,Bueno Alvarez-Arenas M I,Monterrubio-Villa J, et al.Streptococcus agalactiae pleural empyema in a healthy adult[J].Enferm Infecc Microbiol Clin,2002,20:478-479.
[4]
Keefe G P.Streptococcus agalactiae mastitis:a review[J].The Canadian Veterinary Journal La Revue Vétérinaire Canadienne,1997,38(7):429-437.
[5]
Rajagopal L.Understanding the regulation of Group B streptococcal virulence factors[J].Future Microbiology,2009,4(2):201-221.
[6]
Maisey H C,Doran K S,Nizet V.Recent advances in understanding the molecular basis of group B streptococcus virulence [J].Expert Rev Mol Med,2008,10:e27.
[7]
Lang S H,Palmer M.Characterization of streptococcus agalactiae CAMP factor as a pore-forming toxin[J].Journal of Biological Chemistry,2003,278(40):38167-38173.
[8]
Munch-Petersen E,Christie R.Further notes on a lytic phenomenon shown by group B streptococci[J].The Australian Journal of Experimental Biology and Medical Science,1945,23:193-195.
[9]
Milhas D,Clarke C J,Hannun Y A.Sphingomyelin metabolism at the plasma membrane:implications for bioactive sphingolipids[J].FEBS Letters,2010,584(9):1887-1894.
[10]
Titball R W.Bacterial phospholipases C[J].Microbiological Reviews,1993,57(2):347-366.
[11]
Rodi P M,Cabeza M S,Gennaro A M.Detergent solubilization of bovine erythrocytes.Comparison between the insoluble material and the intact membrane[J].Biophysical Chemistry,2006,122(2):114-122.
[12]
Lang S,Xue J,Guo Z,et al.Streptococcus agalactiae CAMP factor binds to GPI-anchored proteins[J].Medical Microbiology and Immunology,2007,196(1):1-10.
[13]
Jorgens D,Sterzik B,fehrenbach F J.Unspecific binding ofgroup B streptococcal cocytolysin(CAMP factor)to immunoglobulins and its possible role in pathoganicity[J].Journal of Experimental Medicine,1987,165(3):720-732.
[14]
Schneewind O,Friedrich K,Lütticken R.Cloning and expression of the CAMP factor of group B streptococci in Escherichia coli[J].Infection and Immunity,1988,56(8):2174-2179.
[15]
Gase K,Ferretti J J,Primeaux C,et al.Identification,cloning,and expression of the CAMP factor gene(cfa) of group A streptococci[J].Infection and Immunity,1999,67(9):4725-4731.
[16]
Jiang M,Babiuk L A,Poner A A.Cloning,sequencingand expression of the CAMP factor gene of Streptococcus uberis[J].Microbial Pathogenesis,1996,20(5):297-307.
[17]
Frey J,Perrin J,Nicolet J.Cloning and expression of a cohemolysin,the CAMP factor of Actinobacillus pleuropneumoniae[J].Infection and Immunity,1989,57(7):2050-2056.
[18]
Stackbrandt E,Goodfellow M.Nucleic acid techniques in bacteri systematics[M].Newyork:awilley-interscience publication,1991:115-175.
[19]
Brown J,Farnsworth R,Wannamaker L W,et al.CAMP factor of group B streptococci:production,assay,and neutralization by sera from immunized rabbits and experimentally infected cows[J].Infection and Immunity,1974,9(2):377-383.
[20]
Podbielski A,Blankenstein O,Lrtticken R.Molecular characterizalion of the cfb gene encoding group B streptococcal CAMP-factor[J].Med Microbiol Immunol,1994,183(5):239-256.
[21]
Darling C L.Standardization and evaluation of the CAMP reaction for the prompt presumptive identification of Streptococcus agalactiaee(Lancelield group B)in clinical material[J].Clin Microbiol,1975,1(2):171-174.
[22]
Phillips E A,Tapsall J W,Smith D D.Rapid tube CAMP test for identification of Streptococcus agalactiae(Lancefield group B)[J].Journal of Clinical Microbiology,1980,12(2):135-137.
[23]
Takaisi-Kikuni N B,Jurgens D,Wecke J,et al.Immunochemical localization of CAMP factor(protein B) in Streptococcus agalactiae[J].Microbios,1997,89(360/361):171-185.
